November 2022 in “Journal of the Endocrine Society” Marijuana use may be linked to lower TSH levels, but the exact cause is unclear.
737 citations,
December 2020 in “Journal of Infection” Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.
241 citations,
March 2000 in “The Journal of Urology” Men over 50 may experience hormone decline causing various symptoms, and proper management is crucial.
67 citations,
April 2007 in “Environmental health perspectives” A woman's health issues were caused by arsenic poisoning from kelp supplements.
33 citations,
June 2021 in “Dermatologic Therapy” COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.
25 citations,
January 2022 in “Endocrine journal” Long COVID patients may have hormonal imbalances linked to their symptoms.
22 citations,
November 2018 in “Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry” This study reviewed the initial symptoms and signs of 966 patients diagnosed with Systemic Lupus Erythematosus (SLE) at the Royal Hospital in Oman from 2006 to 2014. The majority of patients were female (88.7%) with a mean age of 27.6 years. Common symptoms included fatigue (35.22%), weight changes (13.43%), malar rash (37.69%), photosensitivity (35.10%), discoid lupus (17.63%), and hair loss (39.29%). Musculoskeletal issues were prevalent, with arthralgia in 68.75% and myalgia in 55.65%. The study highlighted the need for nationwide and regional collaboration to improve SLE reporting and management.
20 citations,
March 2022 in “Journal of clinical medicine” Nearly half of the studied men with long COVID had low testosterone, including younger men.
18 citations,
July 2016 in “British Journal of Dermatology” Cutaneous lupus erythematosus (CLE) significantly impaired health-related quality of life (HRQoL) in patients, with symptoms including pain, pruritus, fatigue, and photosensitivity. A systematic review identified 482 citations, with 11 studies meeting inclusion criteria, using five patient-reported outcome (PRO) instruments: Skindex (versions 16 and 29), Dermatology Life Quality Index, 36-Item Short-Form Health Survey, and visual analogue scales for pain and pruritus. The review highlighted the limited number of studies on PRO in CLE and emphasized the need for further research to better understand the disease's impact from patients' perspectives.
14 citations,
January 2020 in “Women's health reports” Iron deficiency in menstruating women causes many health issues beyond anemia and needs early detection and treatment.
11 citations,
March 2016 in “Journal of Cosmetic Dermatology” Half of hair restoration surgeons experience body discomfort, especially after follicular unit extraction procedures, and using ergonomic equipment or robotic devices could reduce this discomfort.
10 citations,
February 2017 in “International Journal of Rheumatic Diseases” This study investigated the prevalence of thyroid dysfunction in 100 rheumatoid arthritis (RA) patients and found that 22 had thyroid issues, with hypothyroidism being the most common. Fatigue and hair loss were frequent symptoms, but only weight gain and cold intolerance were significant predictors of hypothyroidism. Additionally, 32 patients tested positive for anti-thyroid peroxidase (antiTPO) autoantibodies. The study highlighted the importance of thorough history taking to identify symptoms like weight gain and cold intolerance for timely hypothyroidism diagnosis in RA patients.
9 citations,
February 2018 in “Journal of Patient-Reported Outcomes” The study aimed to develop patient-reported outcome (PRO) measures for systemic lupus erythematosus (SLE) to capture symptom fluctuations and impacts, following FDA guidelines. Forty-one patients participated in concept elicitation interviews, identifying common symptoms like fatigue (98%), joint pain (93%), and rash (88%), and impacts such as difficulty with chores (61%). The resulting SLE Symptom Severity Diary (SSD) and SLE Impact Questionnaire (SIQ) were refined through patient and clinician feedback. The SSD includes 17 items with an 11-point scale and a 24-hour recall period, while the SIQ has 50 items with a 5-point Likert scale and a 7-day recall period. These PROs were considered comprehensive and relevant, potentially useful for clinical studies and practice.
7 citations,
October 2020 in “Wiener medizinische Wochenschrift” THA is a rare condition with no significant clinical consequences if thyroid function is normal.
6 citations,
December 2023 in “Lancet. Infectious diseases/The Lancet. Infectious diseases” SIM01 significantly reduced post-COVID symptoms and is safe.
3 citations,
April 2023 in “Clinical and Experimental Medicine” The study identified five types of long COVID symptoms and suggests tailored management strategies for each.
3 citations,
December 2015 in “Musculoskeletal care” Many patients on methotrexate experience significant side effects but still continue the medication.
2 citations,
March 2023 in “The Lancet. Respiratory medicine” Long COVID is a serious, long-lasting illness that needs more recognition and support.
2 citations,
June 2020 in “AIDS” Recreational drug use can cause misdiagnosed conditions and drug interactions in HIV patients.
2 citations,
May 2017 in “Endocrinology, diabetes & metabolism case reports” Lugol's solution can cause thyroid problems if used long-term for non-approved reasons.
2 citations,
November 2016 in “PubMed” Robotic hair restoration is efficient, minimally invasive, reduces scarring, and leads to quick healing with high patient satisfaction.
2 citations,
August 2014 in “PubMed” Losartan may help treat Postural Orthostatic Tachycardia Syndrome (POTS) symptoms.
1 citations,
September 2022 in “JAMMI” Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.
1 citations,
January 2021 in “Wits Journal of Clinical Medicine” Long COVID causes lasting symptoms and needs ongoing care.
1 citations,
August 2007 in “Indian Journal of Pediatrics” A girl with symptoms like an autoimmune disorder actually had HIV and a fungal infection, which was hard to diagnose and treat, leading to her death.
September 2024 in “Bulletin of the Russian Military Medical Academy” Iron deficiency is common in female military personnel but doesn't significantly impact daily physical activity.
Anifrolumab treatment for systemic lupus erythematosus (SLE) patients in Denmark significantly improved patient-reported quality of life and decreased disease activity and corticosteroid use. The study involved qualitative in-depth interviews with 14 patients and electronic medical record data from 16 patients. Common symptoms like fatigue, joint pain, and hair loss improved with treatment. Patients reported enhancements in daily activities, social life, and emotional well-being, although some impacts remained. The findings highlight the treatment's positive effects on both subjective experiences and objective health parameters.
The study on Anifrolumab treatment for systemic lupus erythematosus (SLE) patients revealed significant improvements in quality of life and a decrease in systemic corticosteroid use. Conducted through qualitative interviews with 14 patients and electronic medical record data from 16 patients, the research highlighted a reduction in bothersome symptoms such as fatigue, joint pain, and hair loss. Patients reported enhanced daily life activities, social interactions, and emotional well-being post-treatment. Additionally, clinical data showed decreased disease activity and improved laboratory results, supporting the subjective reports of symptom alleviation. These findings underscore the efficacy of Anifrolumab in managing SLE.
May 2024 in “Journal of ayurveda and integrated medical sciences” Amra Beej Majja Churna may help improve Vitamin B12 levels and symptoms in vegans.
February 2024 in “Journal of ayurveda and integrated medical sciences” Ayurvedic medicine helped increase a young woman's hemoglobin levels and improved her anemia symptoms.